Cori Daines

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials”.

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00411-9

N/A

1.9DataRank · unranked

95 citations

Lael M. Yonker, F. Vermeulen, Dario Prais, Rachel W. Linnemann, Aaron Trimble +92 more

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00504-5

N/A

1.5DataRank · unranked

67 citations

Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more

Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma

The Journal of Allergy and Clinical Immunology In Practice(2023)10.1016/j.jaip.2023.12.010

N/A

0.624DataRank · unranked

13 citations

Stephen C. Lazarus, Jerry A. Krishnan, Kathryn Blake, Christine A. Sorkness, Anne‐Marie Dyer +83 more

The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions

Journal of Allergy and Clinical Immunology(2021)10.1016/j.jaci.2021.10.035

N/A

0.621DataRank · unranked

62 citations

Rosalind J. Wright, Anastasia Ivanova, Elliot Israel, Lisa M. LaVange, Praveen Akuthota +95 more

Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.08.007

N/A

0.464DataRank · unranked

21 citations

Michael W. Konstan, Jennifer L. Taylor‐Cousar, Isabelle Fajac, Alex Horsley, Sivagurunathan Sutharsan +11 more

Associations of Sputum Biomarkers with Clinical Outcomes in People with Cystic Fibrosis

medRxiv(2022)10.1101/2022.05.25.22275540

N/A

0DataRank · unranked

2 citations

Natalia Argel, Fadi Asfour, Perry Brown, Barbara A. Chatfield, David Cox +33 more

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

iScience(2024)10.1016/j.isci.2024.108835

N/A

0DataRank · unranked

9 citations

Natalia Argel, Fadi Asfour, Perry Brown, Barbara A. Chatfield, David Cox +33 more